Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Zymeworks Inc.(ZYME) | 22,970,388 | 22,970,388 | 0 | $600.45M | $608.49M | 29.91% | +$8.04M |
| Anaptysbio Inc | 7,880,094 | 7,880,094 | 0 | $531.91M | $396.05M | 19.47% | -$135.85M |
| CG Oncology, Inc.(CGON) | 1,494,300 | 1,871,892 | +377,592 | $106.17M | $132.70M | 6.52% | +$26.53M |
| Eton Pharmaceuticals, Inc.(ETON) | 2,171,938 | 2,470,920 | +298,982 | $78.62M | $127.23M | 6.25% | +$48.60M |
| First Tracks Biotherapeutics | 3,174,519 | 3,174,519 | 0 | $63.87M | $112.50M | 5.53% | +$48.63M |
| Aktis Oncology, Inc.(AKTS) | 4,824,469 | 4,824,469 | 0 | $155.49M | $93.93M | 4.62% | -$61.56M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 1,389,276 | 1,389,276 | 0 | $75.77M | $76.85M | 3.78% | +$1.08M |
| Alto Neuroscience, Inc.SHSCOM(ANRO) | 0 | 2,232,000 | +2,232,000 | $0 | $56.98M | 2.80% | +$56.98M |
| Lakefront Biotherapeutics NVADR(LKFT) | 1,667,119 | 1,667,119 | 0 | $49.98M | $49.43M | 2.43% | -$550.1K |
| Erasca, Inc.(ERAS) | 330,000 | 2,950,000 | +2,620,000 | $6.05M | $43.25M | 2.13% | +$37.20M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 6,728,116 | 3,028,116 | -3,700,000 | $72.87M | $40.79M | 2.01% | -$32.08M |
| Neurogene Inc.(NGNE) | 1,271,342 | 1,271,342 | 0 | $39.98M | $35.37M | 1.74% | -$4.61M |
| Attovia Therapeutics IncCOM ADDED | 0 | 2,024,010 | +2,024,010 | $0 | $34.69M | 1.71% | +$34.69M |
| Fulcrum Therapeutics, Inc.(FULC) | 6,549,866 | 6,803,785 | +253,919 | $23.97M | $25.17M | 1.24% | +$1.20M |
| Adarx Pharmaceuticals IncCOM ADDED | 0 | 1,150,000 | +1,150,000 | $0 | $22.93M | 1.13% | +$22.93M |
| Stoke Therapeutics, Inc.(STOK) | 735,000 | 835,000 | +100,000 | $24.05M | $21.71M | 1.07% | -$2.34M |
| Zenas BioPharma, Inc.(ZBIO) | 789,500 | 789,500 | 0 | $20.04M | $21.29M | 1.05% | +$1.26M |
| Electra Therapeutics IncCOM ADDED | 0 | 1,700,000 | +1,700,000 | $0 | $19.13M | 0.94% | +$19.13M |
| Atara Biotherapeutics Inc | 1,552,000 | 1,552,000 | 0 | $17.82M | $13.19M | 0.65% | -$4.62M |
| Capricor Therapeutics, Inc.(CAPR) | 0 | 1,376,580 | +1,376,580 | $0 | $13.04M | 0.64% | +$13.04M |
| Xencor, Inc.(XNCR) | 0 | 500,000 | +500,000 | $0 | $12.47M | 0.61% | +$12.47M |
| Odyssey Therapeutics Inc | 555,555 | 555,555 | 0 | $10.39M | $12.34M | 0.61% | +$1.95M |
| Aura Biosciences, Inc.(AURA) | 1,666,667 | 1,666,667 | 0 | $11.83M | $10.47M | 0.51% | -$1.37M |
| Nurix Therapeutics, Inc.(NRIX) | 270,000 | 375,000 | +105,000 | $6.55M | $8.89M | 0.44% | +$2.34M |
| Braveheart Bio IncSHSCOM ADDED | 0 | 416,700 | +416,700 | $0 | $8.42M | 0.41% | +$8.42M |
| Pharvaris N V COM | 235,000 | 235,000 | 0 | $8.13M | $7.45M | 0.37% | -$672.1K |
| Eikon Therapeutics, Inc.(EIKN) | 732,606 | 855,634 | +123,028 | $9.56M | $6.88M | 0.34% | -$2.68M |
| Eloxx Pharmaceuticals Inc | 400,000 | 400,000 | 0 | $5.55M | $6.12M | 0.30% | +$572.0K |
| Aardvark Therapeutics Inc | 396,194 | 720,028 | +323,834 | $2.28M | $3.79M | 0.19% | +$1.51M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 2,823,126 | 889,607 | -1,933,519 | $21.51M | $3.65M | 0.18% | -$17.86M |
| Tcgx Acquisition CorpCL AORD ADDED | 0 | 250,000 | +250,000 | $0 | $3.13M | 0.15% | +$3.13M |
| Zura Bio LimitedCL A(ZURA) | 1,179,715 | 679,715 | -500,000 | $6.96M | $2.83M | 0.14% | -$4.13M |
| Helix Acquisition Corp. IIICL A(HLXC) | 200,000 | 200,000 | 0 | $2.13M | $2.12M | 0.10% | -$4.0K |
| Contineum Therapeutics, Inc.CL A(CTNM) | 0 | 64,303 | +64,303 | $0 | $862.9K | 0.04% | +$862.9K |
| Legend Biotech CorporationADS(LEGN) | 800,000 | 0 | -800,000 | $23.10M | $0 | — | -$23.10M |
| MBX Biosciences, Inc.(MBX) | 388,500 | 0 | -388,500 | $21.45M | $0 | — | -$21.45M |
| Mereo BioPharma Group plcADS(MREO) | 1,000,000 | 0 | -1,000,000 | $317.7K | $0 | — | -$317.7K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 625,000 | 0 | -625,000 | $6.78M | $0 | — | -$6.78M |
| Relay Therapeutics, Inc.(RLAY) | 697,948 | 0 | -697,948 | $13.06M | $0 | — | -$13.06M |
| Surrozen, Inc.W EXP 08 01 203(SRZN) | 4,444 | 0 | -4,444 | $115.3K | $0 | — | -$115.3K |